FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2125549393> ?p ?o ?g. }

• W2125549393 abstract "Monoclonal antibodies block interleukin-2 receptors on alloantigen-reactive T-Lymphocytes and induce selective immunosuppression. It is postulated that induction therapy with these agents in pediatric transplantation may decrease acute rejection and improve graft survival with no significant side effect or increase in the incidence of viral infections.The aim of this study was to examine the effects of interleukin 2 receptor blockers on patient and graft survival in renal-transplanted children.One hundred and eighty six children aged 7-13 years who received renal transplantation in university-affiliated hospital between 2003 and 2012 were enrolled in the study. All patients received prednisolone, cyclosporine and mycophenolate mofetil or azathioprine as basic immunosuppressive therapy. Patients were divided into two groups according to receiving induction therapy with IL2-receptor blockers. We investigated for acute rejection episodes, Cytomegalovirus (CMV) and BK virus infection and one and three year's survival of the patients and the grafts.From 186 renal-transplanted children included in this study, 36 patients were in treated group (group 1) and 150 patients in control group (group 2). The mean age of the patients was 10.4 ± 2 years and 55.6% were males. In first six months of transplantation, eight patients in group one had one episode of acute rejection and no one had two episodes. Early acute rejection rate was 8.36 (22%). In the control group, 37 patients had one episode and three patients had two episodes of acute rejection (rejection rate 28.6%). Therefore, early acute rejection rates were lower in group one. Late acute rejection rates did not show any difference in group 1 and group 2 (27.7% vs. 27.3% respectively). There was lower prevalence of steroid-resistance rejection in group 1 patients (5.5%) compared with 6.6% in group 2, but it did not reach statistical significance. None of the patients in IL2-R blocker group died at one year follow-up (patient survival 100%). However, in control group, four (2.6%) patients died toward the end of first year (patient survival 97.4%). When patients in group 1 and group 2 were age and sex matched with equal number the difference was significant (P < 0.05).Induction therapy with IL2-R blockers reduced the rate of early acute rejection, but had no effect on late acute rejections. Patient and graft survival were better in treated group, but did not reach statistical significance. A longer period of follow-up may be required to discern a clear advantage for induction therapy with these agents." @default.
• W2125549393 created "2016-06-24" @default.
• W2125549393 creator A5000122192 @default.
• W2125549393 creator A5011083384 @default.
• W2125549393 creator A5022472851 @default.
• W2125549393 creator A5035448854 @default.
• W2125549393 creator A5052926012 @default.
• W2125549393 creator A5084328533 @default.
• W2125549393 date "2014-07-05" @default.
• W2125549393 modified "2023-10-10" @default.
• W2125549393 title "Effects of Interleukin 2 Receptor Blockers on Patient and Graft Survival in Renal-Transplanted Children" @default.
• W2125549393 cites W1756759934 @default.
• W2125549393 cites W1980998626 @default.
• W2125549393 cites W1985137297 @default.
• W2125549393 cites W2004229127 @default.
• W2125549393 cites W2028001665 @default.
• W2125549393 cites W2033506916 @default.
• W2125549393 cites W2043957629 @default.
• W2125549393 cites W2044215385 @default.
• W2125549393 cites W2051554858 @default.
• W2125549393 cites W2068154871 @default.
• W2125549393 cites W2076451571 @default.
• W2125549393 cites W2079142029 @default.
• W2125549393 cites W2085971634 @default.
• W2125549393 cites W2089268585 @default.
• W2125549393 cites W2095107584 @default.
• W2125549393 cites W2108647254 @default.
• W2125549393 cites W2129356278 @default.
• W2125549393 cites W2154028793 @default.
• W2125549393 cites W2413200629 @default.
• W2125549393 cites W68282923 @default.
• W2125549393 doi "https://doi.org/10.5812/numonthly.18641" @default.
• W2125549393 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4317716" @default.
• W2125549393 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25695021" @default.
• W2125549393 hasPublicationYear "2014" @default.
• W2125549393 type Work @default.
• W2125549393 sameAs 2125549393 @default.
• W2125549393 citedByCount "0" @default.
• W2125549393 countsByYear W21255493932016 @default.
• W2125549393 crossrefType "journal-article" @default.
• W2125549393 hasAuthorship W2125549393A5000122192 @default.
• W2125549393 hasAuthorship W2125549393A5011083384 @default.
• W2125549393 hasAuthorship W2125549393A5022472851 @default.
• W2125549393 hasAuthorship W2125549393A5035448854 @default.
• W2125549393 hasAuthorship W2125549393A5052926012 @default.
• W2125549393 hasAuthorship W2125549393A5084328533 @default.
• W2125549393 hasBestOaLocation W21255493931 @default.
• W2125549393 hasConcept C126322002 @default.
• W2125549393 hasConcept C141071460 @default.
• W2125549393 hasConcept C170493617 @default.
• W2125549393 hasConcept C203014093 @default.
• W2125549393 hasConcept C2776715498 @default.
• W2125549393 hasConcept C2776760755 @default.
• W2125549393 hasConcept C2777371288 @default.
• W2125549393 hasConcept C2779134260 @default.
• W2125549393 hasConcept C2780252810 @default.
• W2125549393 hasConcept C2780303639 @default.
• W2125549393 hasConcept C2911091166 @default.
• W2125549393 hasConcept C71924100 @default.
• W2125549393 hasConcept C90924648 @default.
• W2125549393 hasConceptScore W2125549393C126322002 @default.
• W2125549393 hasConceptScore W2125549393C141071460 @default.
• W2125549393 hasConceptScore W2125549393C170493617 @default.
• W2125549393 hasConceptScore W2125549393C203014093 @default.
• W2125549393 hasConceptScore W2125549393C2776715498 @default.
• W2125549393 hasConceptScore W2125549393C2776760755 @default.
• W2125549393 hasConceptScore W2125549393C2777371288 @default.
• W2125549393 hasConceptScore W2125549393C2779134260 @default.
• W2125549393 hasConceptScore W2125549393C2780252810 @default.
• W2125549393 hasConceptScore W2125549393C2780303639 @default.
• W2125549393 hasConceptScore W2125549393C2911091166 @default.
• W2125549393 hasConceptScore W2125549393C71924100 @default.
• W2125549393 hasConceptScore W2125549393C90924648 @default.
• W2125549393 hasIssue "4" @default.
• W2125549393 hasLocation W21255493931 @default.
• W2125549393 hasLocation W21255493932 @default.
• W2125549393 hasLocation W21255493933 @default.
• W2125549393 hasLocation W21255493934 @default.
• W2125549393 hasOpenAccess W2125549393 @default.
• W2125549393 hasPrimaryLocation W21255493931 @default.
• W2125549393 hasRelatedWork W192738125 @default.
• W2125549393 hasRelatedWork W1972954852 @default.
• W2125549393 hasRelatedWork W2026954685 @default.
• W2125549393 hasRelatedWork W2049626078 @default.
• W2125549393 hasRelatedWork W2056932738 @default.
• W2125549393 hasRelatedWork W2070231299 @default.
• W2125549393 hasRelatedWork W2403888360 @default.
• W2125549393 hasRelatedWork W2413668559 @default.
• W2125549393 hasRelatedWork W2439695451 @default.
• W2125549393 hasRelatedWork W2516753610 @default.
• W2125549393 hasVolume "6" @default.
• W2125549393 isParatext "false" @default.
• W2125549393 isRetracted "false" @default.
• W2125549393 magId "2125549393" @default.
• W2125549393 workType "article" @default.